Squamous cell carcinoma head and neck cancer (HNSCC)
Clinical trials for Squamous cell carcinoma head and neck cancer (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new Squamous cell carcinoma head and neck cancer (HNSCC) trials appear
Sign up with your email to follow new studies for Squamous cell carcinoma head and neck cancer (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a primer drug make chemotherapy work better for frail head and neck cancer patients?
Disease control Not yet recruitingThis phase 2 trial tests whether giving toripalimab first can prime head and neck cancer tumors to respond better to the chemotherapy drug paclitaxel. The study enrolls 22 patients with metastatic or incurable head and neck squamous cell carcinoma who have a reduced performance s…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New study: can early palliative care help head and neck cancer patients suffer less?
Symptom relief Not yet recruitingThis study tests whether adding palliative care early — alongside standard chemoradiotherapy — can improve symptoms and quality of life for people with advanced head and neck cancer that cannot be surgically removed. Researchers will compare two groups: one receiving standard tre…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Sponsor: Portuguese Oncology Institute, Coimbra • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC